Skip to Main Content

Adriana Emilce Galvan, PhD

Postdoctoral Associate

Cellular Biology & Pharmacology

Office: AHC1 322

Phone: 305-348-1479


Adriana Galván is a researcher in Dr. Barry Rosen’s lab. Currently, her research focuses on the determination of the biosynthetic pathway of an arsenic-containing recently identified antibiotic and the degradation pathways of other arsenical compounds. 


PhD, Biological Sciences, National University of Tucumán 
BS, Biotechnology, National University of Tucumán 

Areas of interest/specialization  

Galván is interested in the metabolic pathways that are involved in the synthesis and degradation of organoarsenicals compounds. Her research is based in the discovery of the genes involved in the arsenic biotransformation and the analysis of proteins expression/activity under certain stress condition. Arsenic metabolization is later evaluated by mass spectrometry (HPLC-ICP-MS). 

Research areas/interest  

  • Microbiology, molecular biology, genetic engineering and biophysics techniques
  • Antimicrobial activity
  • Mass Spectrometry: Inductively Coupled Plasma Detection System (ICP-MS)


  1. 2021. “Semi-synthesis of theorganoarsenicalantibiotic arsinothricin” Suzol S*; Howlader AH*; Galván AE; Radhakrishnan M; Wnuk S; Rosen BP, and Yoshinaga M. Journal of Natural Products. DOI: 10.1021/acs.jnatprod.0c00522. 
  2. 2019. “Reduction oforganoarsenicalherbicides and antimicrobial growth promoters by the legume symbiont Sinorhizobium meliloti”.  Yan Y*; Chen J*; Galván AE; Garbinski L; Zhu YG; Rosen BP; Yoshinaga M. Environ Sci Technol. DOI: 10.1021/acs.est.9b04026.  
  3. 2019. “Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic”. Sarkarai Nadar V*; Chen J*; Dheeman DS*; Galván AE; Yoshinaga-Sakurai K; Kandavelu P; Sankaran B; Kuramata M; Ishikawa S; Rosen BP; Yoshinaga M. Nature, Communication Biology. DOI: 10.1038/s42003-019-0365-y.  

View more publications